AMLODIPINE VIATRIS GENERIQUES 5 mg, hard capsule 30 capsules
Active ingredients: Amlodipine, Amlodipine besylate
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule30 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMLODIPINE VIATRIS GENERIQUES 5 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 30 gélule(s)
- Marketing authorisation holder
- VIATRIS UP
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 May 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62204255CIP73334167CIP133400933341671Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AMLODIPINEgélule | 5 mg · une gélule | FT |
| AMLODIPINE (BÉSILATE D')gélule | 6,983 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.